-
2
-
-
0031005627
-
Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy
-
A Southwest Oncology Group study.
-
(1997)
Blood
, vol.89
, pp. 3323
-
-
Leith, C.P.1
Kopecky, K.J.2
Godwind, J.3
McConnel, T.4
Slovak, M.L.5
Chen, I.M.6
Head, D.R.7
Appelbaum, F.R.8
Willman, C.L.9
-
3
-
-
0029963038
-
The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia
-
(1996)
Leukemia
, vol.10
, Issue.SUPPL. 1
-
-
List, A.F.1
-
9
-
-
0028182306
-
Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia
-
(1994)
Cancer Genetics Cytogenetics
, vol.73
, pp. 1
-
-
Swansbury, G.J.1
Lawler, S.D.2
Alimena, G.3
Arthur, D.4
Berger, R.5
Van den Berghe, H.6
Bloomfield, C.D.7
de la Chappelle, A.8
Dewald, G.9
Garson, O.M.10
-
14
-
-
0006254476
-
Reports on public health and medical subjects: The natural duration of cancer
-
Her Majesty Stationary Office
-
(1926)
, vol.33
, pp. 1
-
-
Greenwood, M.1
-
17
-
-
0026570583
-
The treatment of acute myeloid leukaemia preceded by the myelodysplastic syndrome
-
(1992)
Leukemia Research
, vol.16
, pp. 101
-
-
Hamblin, T.1
-
18
-
-
0025138479
-
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly
-
(1990)
Journal of Clinical Oncology
, vol.8
, pp. 272
-
-
Tilly, H.1
Castaigne, S.2
Bordessoule, D.3
Casassus, P.4
Le Prise, P.Y.5
Tertian, G.6
Desablens, B.7
Henry-Amar, M.8
Degos, L.9
-
19
-
-
0019979989
-
Cytosine arabinoside with daunorubincin or adriamycin for therapy of acute myelocytic leukemia: A CALGB study
-
(1982)
Blood
, vol.60
, pp. 454
-
-
Yates, J.1
Glidewell, O.2
Wiernick, P.3
Cooper, M.R.4
Steinberg, D.5
Dosik, H.6
Levy, R.7
Hoagland, C.8
Henry, P.9
Gottlieb, A.10
Cornell, C.11
Berenberg, J.12
Hutchinson, J.L.13
Raich, P.14
Nissen, N.15
Ellison, R.R.16
Frelick, R.17
James, G.W.18
Falkson, F.19
Green, M.20
Henderson, E.21
Leone, L.22
Holland, J.F.23
more..
-
20
-
-
0343045296
-
Mitoxantrone versus daunorubicin in induction-consolidation chemotheraphy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: Final report
-
European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
-
(1998)
Journal of Clinical Oncology
, vol.16
, pp. 872
-
-
Lowenberg, B.1
Sucio, S.2
Archimbaud, E.3
Haak, H.4
Stryckmans, P.5
de Cataldo, R.6
Dekker, A.W.7
Berneman, Z.N.8
Thyss, A.9
van der Leile, J.10
Sonneveld, P.11
Visani, G.12
Fillet, G.13
Hayat, M.14
Hagemeijer, A.15
Solbu, G.16
Zittoun, R.17
-
21
-
-
9244253691
-
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75
-
(1996)
Leukemia
, vol.10
, pp. 389
-
-
Reiffer, J.1
Huguet, F.2
Stoppa, A.M.3
Molina, L.4
Marit, G.5
Attal, M.6
Gastaut, J.A.7
Michallet, M.8
Lepeu, G.9
Broustet, A.10
Pris, J.11
Maraninchi, D.12
Holard, D.13
Faberes, C.14
Mercier, M.15
Hurteloup, P.16
Danel, P.17
Tellier, Z.18
Berthaud, P.19
-
22
-
-
0029015209
-
A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern (E1490)
-
(1995)
Blood
, vol.86
, pp. 457
-
-
Rowe, J.M.1
Andersen, J.W.2
Mazza, J.J.3
Bennet, J.M.4
Paietta, E.5
Hayes, F.A.6
Oette, D.7
Cassileth, P.A.8
Stadtmauer, E.A.9
Wiernik, P.H.10
-
23
-
-
0029068452
-
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia
-
AML Cooperative Study Group.
-
(1995)
New England Journal of Medicine
, vol.332
, pp. 1678
-
-
Dombret, H.1
Chastang, C.2
Fenaux, P.3
Reiffers, J.4
Bordessoule, D.5
Bouabdallah, R.6
Mandelli, F.7
Ferrant, A.8
Auzanneau, G.9
Tilly, H.10
Yver, A.11
Degos, L.12
-
24
-
-
0029033064
-
Granulocyte-macrophage colony-stimulating factor after initial chemotheraphy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B
-
(1995)
New England Journal of Medicine
, vol.332
, pp. 1671
-
-
Stone, R.M.1
Berg, D.T.2
George, S.L.3
Dodge, R.K.4
Paciucci, P.A.5
Schulman, P.6
Lee, E.J.7
Moore, J.O.8
Powell, B.L.9
Schiffer, C.A.10
-
25
-
-
0004313674
-
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients
-
Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM).
-
(1998)
Blood
, vol.91
, pp. 2722
-
-
Witz, F.1
Sandoun, A.2
Perrin, M.C.3
Berthou, C.4
Briere, J.5
Cahn, J.Y.6
Lioure, B.7
Witz, B.8
Francois, S.9
Desablens, B.10
Pignon, B.11
Le Prise, P.Y.12
Audhuy, B.13
Caillot, D.14
Casassus, P.15
Delain, M.16
Christian, B.17
Tellier, Z.18
Polin, V.19
Hurteloup, P.20
Harousseau, J.L.21
more..
-
28
-
-
8944259891
-
De novo AML with dysplastic hematopoiesis: Cytogenetic and prognosis significance
-
(1996)
Leukemia
, vol.10
, pp. 946
-
-
Gahn, B.1
Haase, D.2
Unterhalt, M.3
Drescher, M.4
Schoch, C.5
Fonatsch, C.6
Terstappen, L.W.7
Hiddemann, W.8
Buchner, T.9
Bennett, J.M.10
Worman, B.11
|